Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Isaacs Syndrome

ClinicalTrials.gov lists 3 trials for Isaacs Syndrome or a narrower condition beneath it. National Institute of Neurological Disorders and Stroke (NINDS) has the most among industry and government lead sponsors, with 1.

MeSH D020386 Musculoskeletal Diseases C05 C10
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Trials started per year Trials started per year 3 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 3 Lead sponsors Lead sponsors 1 Publications Publications 2 Prevalence Prevalence 4 Rare-disease identity Rare-disease identity 2 Trials started per year Trials started per year 3 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 3 Lead sponsors Lead sponsors 1 Publications Publications 2 Prevalence Prevalence 4 Rare-disease identity Rare-disease identity 2

Rows recorded per section

2 sections measured, none recorded · 1 not measured yet · 1 not computed

3 of the 3 trials are tagged with Isaacs Syndrome itself; the rest are tagged with a narrower condition beneath it.

Get the Isaacs Syndrome report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Isaacs Syndrome trials start? (3)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Observational

Top of scale: 1

2001: 1 trials (Observational 1) 2010: 1 trials (Observational 1) 2024: 1 trials (Observational 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2024 1
2010 1
2001 1

No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 3 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Isaacs Syndrome trials in? (1)

Shown in this order: phase order.

Trials by phase
Phase Trials
Observational 3

How many Isaacs Syndrome trials are recruiting? (3)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 1
Completed 1
Unknown status 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Isaacs Syndrome trials? (1)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
National Institute of Neurological Disorders and Stroke (NINDS) 1

Which publications cover Isaacs Syndrome? (2)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain : a journal of neurology 2010 Yes
Acute oxaliplatin-induced peripheral nerve hyperexcitability. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002 No

Prevalence (4)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Isaacs syndrome Cases families Worldwide Not stated Exact
Isaacs syndrome Point prevalence <1 / 1 000 000 Worldwide Not stated Exact
Isaacs syndrome Point prevalence <1 / 1 000 000 Worldwide Not stated Exact
Isaacs syndrome Cases families Worldwide Not stated Exact

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Isaacs syndrome 84142 Exact Orphadata Science knowledge files, Product 1
Isaacs syndrome 84142 Exact Orphanet Rare Disease Ontology (ORDO)

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages